| 臺大學術典藏 |
2018-09-10T08:03:57Z |
Good response to gefitinib in lung adenocarcinoma harboring coexisting EML4-ALK fusion gene and EGFR mutation
|
Kuo, Y.-W. and Wu, S.-G. and Ho, C.-C. and Shih, J.-Y.; CHAO-CHI HO; JIN-YUAN SHIH |
| 臺大學術典藏 |
2010 |
Good response to gefitinib in lung adenocarcinoma harboring coexisting EML4-ALK fusion gene and EGFR mutation
|
Kuo Y.-W.; SHANG-GIN WU; Ho C.-C.; Shih J.-Y. |
| 臺大學術典藏 |
2020-08-13T06:33:56Z |
Good response to gefitinib in lung adenocarcinoma harboring coexisting EML4-ALK fusion gene and EGFR mutation
|
Kuo Y.-W.;Wu S.-G.;Ho C.-C.;Jin-Yuan Shih; Kuo Y.-W.; Wu S.-G.; Ho C.-C.; JIN-YUAN SHIH |
| 臺大學術典藏 |
2021-08-24T00:33:36Z |
Good response to gefitinib in lung adenocarcinoma harboring coexisting EML4-ALK fusion gene and EGFR mutation
|
YAO-WEN KUO; Wu S.-G.; Ho C.-C.; Shih J.-Y. |
| 國立臺灣大學 |
2008 |
Good Response to Gefitinib in Lung Adenocarcinoma of Complex Epidermal Growth Factor Receptor (Egfr) Mutations with the Classical Mutation Pattern
|
吳尚俊; 張逸良; 巫震宇; 楊志新; 余忠仁; 蔡孟峰; 施金元; 楊泮池; WU, SHANG-GIN; CHANG, YIH-LEONG; WU, JENN-YU; YANG, CHIH-HSIN; YU, CHONG-JEN; TSAI, MENG-FENG; SHIH, JIN-YUAN; YANG, PAN-CHYR |
| 臺大學術典藏 |
2018-09-10T07:05:53Z |
Good response to gefitinib in lung adenocarcinoma of complex epidermal growth factor receptor (EGFR) mutations with the classical mutation pattern
|
JIN-YUAN SHIH; PAN-CHYR YANG; Chong-Jen Yu; YIH-LEONG CHANG; Wu, S.-G. and Chang, Y.-L. and Hsu, Y.-C. and Wu, J.-Y. and Yang, C.-H. and Yu, C.-J. and Tsai, M.-F. and Shih, J.-Y. and Yang, P.-C. |
| 臺大學術典藏 |
2020-03-06T05:26:30Z |
Good response to gefitinib in lung adenocarcinoma of complex epidermal growth factor receptor (EGFR) mutations with the classical mutation pattern
|
Wu S.-G.; YIH-LEONG CHANG; Hsu Y.-C.; Wu J.-Y.; Yang C.-H.; Yu C.-J.; Tsai M.-F.; Shih J.-Y.; Yang P.-C. |
| 臺大學術典藏 |
2008 |
Good response to gefitinib in lung adenocarcinoma of complex epidermal growth factor receptor (EGFR) mutations with the classical mutation pattern
|
Wu S.-G.; Chang Y.-L.; Hsu Y.-C.; Wu J.-Y.; Yang C.-H.; Yu C.-J.; Tsai M.-F.; JIN-YUAN SHIH; Yang P.-C. |
| 臺大學術典藏 |
2008 |
Good response to gefitinib in lung adenocarcinoma of complex epidermal growth factor receptor (EGFR) mutations with the classical mutation pattern
|
Wu S.-G.; YIH-LEONG CHANG; Hsu Y.-C.; Wu J.-Y.; Yang C.-H.; Yu C.-J.; Tsai M.-F.; Shih J.-Y.; Yang P.-C. |
| 臺大學術典藏 |
2020-05-26T09:27:21Z |
Good response to gefitinib in lung adenocarcinoma of complex epidermal growth factor receptor (EGFR) mutations with the classical mutation pattern
|
Yang P.-C.;Shih J.-Y;Tsai M.-F;Yu C.-J;Chih-Hsin Yang;Wu J.-Y;Hsu Y.-C;Chang Y.-L;Wu S.-G; Wu S.-G; Chang Y.-L; Hsu Y.-C; Wu J.-Y; CHIH-HSIN YANG; Yu C.-J; Tsai M.-F; Shih J.-Y; Yang P.-C. |
| 臺大學術典藏 |
2020-08-12T08:25:31Z |
Good response to gefitinib in lung adenocarcinoma of complex epidermal growth factor receptor (EGFR) mutations with the classical mutation pattern
|
SHANG-GIN WU; Chang Y.-L.; Hsu Y.-C.; Wu J.-Y.; Yang C.-H.; Yu C.-J.; Tsai M.-F.; Shih J.-Y.; Yang P.-C. |
| 臺大學術典藏 |
2020-12-02T02:34:29Z |
Good response to gefitinib in lung adenocarcinoma of complex epidermal growth factor receptor (EGFR) mutations with the classical mutation pattern
|
Wu S.-G.; Chang Y.-L.; Hsu Y.-C.; Wu J.-Y.; Yang C.-H.; Yu C.-J.; Tsai M.-F.; Shih J.-Y.; Pan-Chyr Yang; Wu S.-G.; Chang Y.-L.; Hsu Y.-C.; Wu J.-Y.; Yang C.-H.; Yu C.-J.; Tsai M.-F.; Shih J.-Y.; PAN-CHYR YANG |
| 臺大學術典藏 |
2022-06-27T07:07:53Z |
Good response to gefitinib in lung adenocarcinoma of complex epidermal growth factor receptor (EGFR) mutations with the classical mutation pattern
|
Wu S.-G.; Chang Y.-L.; Hsu Y.-C.; Wu J.-Y.; Yang C.-H.; CHONG-JEN YU; Tsai M.-F.; Shih J.-Y.; Yang P.-C. |
| 大葉大學 |
2008-12-5 |
Good Response to Gefitinib in Lung Adenocarcinoma of Complex Epidermal Growth Factor Receptor (EGFR) Mutations with the Classical Mutation Pattern.
|
Wu, SG;Chang, YL;Hsu, YC;Wu, JY;Yang, CH;Yu, CJ;Tsai, Meng-Feng;Shih, JY;Yang, PC |
| 大葉大學 |
2008-12-05 |
Good Response to Gefitinib in Lung Adenocarcinoma of Complex Epidermal Growth Factor Receptor (EGFR) Mutations with the Classical Mutation Pattern.
|
Wu, SG;Chang, YL;Hsu, YC;Wu, JY;Yang, CH;Yu, CJ;Tsai, Meng-Feng;Shih, JY;Yang, PC |
| 臺大學術典藏 |
2018-09-10T08:28:52Z |
Good response to pemetrexed in patients of lung adenocarcinoma with epidermal growth factor receptor (EGFR) mutations
|
Wu, S.-G. and Yang, C.-H. and Yu, C.-J. and Lee, J.-H. and Hsu, Y.-C. and Chang, Y.-L. and Shih, J.-Y. and Yang, P.-C.; YIH-LEONG CHANG; Chong-Jen Yu; JIN-YUAN SHIH |
| 臺大學術典藏 |
2020-03-06T05:26:25Z |
Good response to pemetrexed in patients of lung adenocarcinoma with epidermal growth factor receptor (EGFR) mutations
|
Wu S.-G.; Yang C.-H.; Yu C.-J.; Lee J.-H.; Hsu Y.-C.; YIH-LEONG CHANG; Shih J.-Y.; Yang P.-C. |
| 臺大學術典藏 |
2020-03-07T06:56:38Z |
Good response to pemetrexed in patients of lung adenocarcinoma with epidermal growth factor receptor (EGFR) mutations
|
Wu S.-G. ;Yang C.-H. ;Yu C.-J. ;Lee J.-H. ;Hsu Y.-C. ;Yih-Leong Chang ;Shih J.-Y. ;Yang P.-C.; Wu S.-G.; Yang C.-H.; Yu C.-J.; Lee J.-H.; Hsu Y.-C.; YIH-LEONG CHANG; Shih J.-Y.; Yang P.-C. |
| 臺大學術典藏 |
2020-05-26T09:27:12Z |
Good response to pemetrexed in patients of lung adenocarcinoma with epidermal growth factor receptor (EGFR) mutations
|
CHIH-HSIN YANG; Yu C.-J; Lee J.-H; Hsu Y.-C; Chang Y.-L; Shih J.-Y; Yang P.-C.; Wu S.-G;Chih-Hsin Yang;Yu C.-J;Lee J.-H;Hsu Y.-C;Chang Y.-L;Shih J.-Y;Yang P.-C.; Wu S.-G |
| 臺大學術典藏 |
2011 |
Good response to pemetrexed in patients of lung adenocarcinoma with epidermal growth factor receptor (EGFR) mutations
|
Shang-Gin Wu ;Yang C.-H. ;Yu C.-J. ;Lee J.-H. ;Hsu Y.-C. ;Chang Y.-L. ;Shih J.-Y. ;Yang P.-C.; SHANG-GIN WU; Yang C.-H.; Yu C.-J.; Lee J.-H.; Hsu Y.-C.; Chang Y.-L.; Shih J.-Y.; Yang P.-C. |
| 臺大學術典藏 |
2020-08-13T06:33:53Z |
Good response to pemetrexed in patients of lung adenocarcinoma with epidermal growth factor receptor (EGFR) mutations
|
Chang Y.-L.; JIN-YUAN SHIH; Yang P.-C.; Hsu Y.-C.; Lee J.-H.; Wu S.-G.;Yang C.-H.;Yu C.-J.;Lee J.-H.;Hsu Y.-C.;Chang Y.-L.;Jin-Yuan Shih;Yang P.-C.; Wu S.-G.; Yang C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2020-12-02T02:34:09Z |
Good response to pemetrexed in patients of lung adenocarcinoma with epidermal growth factor receptor (EGFR) mutations
|
Wu S.-G.; Yang C.-H.; Yu C.-J.; Lee J.-H.; Hsu Y.-C.; Chang Y.-L.; Shih J.-Y.; Pan-Chyr Yang; Wu S.-G.; Yang C.-H.; Yu C.-J.; Lee J.-H.; Hsu Y.-C.; Chang Y.-L.; Shih J.-Y.; PAN-CHYR YANG |
| 臺大學術典藏 |
2021-07-13T06:04:40Z |
Good response to pemetrexed in patients of lung adenocarcinoma with epidermal growth factor receptor (EGFR) mutations
|
Wu S.-G.; Yang C.-H.; Yu C.-J.; LEE JIH-HSIANG; Hsu Y.-C.; Chang Y.-L.; Shih J.-Y.; Yang P.-C. |
| 臺大學術典藏 |
2022-02-21T03:52:42Z |
Good response to pemetrexed in patients of lung adenocarcinoma with epidermal growth factor receptor (EGFR) mutations
|
Wu S.-G.; Yang C.-H.; Yu C.-J.; JIH-HSIANG LEE; Hsu Y.-C.; Chang Y.-L.; Shih J.-Y.; Yang P.-C. |
| 臺大學術典藏 |
2022-06-27T07:07:35Z |
Good response to pemetrexed in patients of lung adenocarcinoma with epidermal growth factor receptor (EGFR) mutations
|
Wu S.-G.; Yang C.-H.; CHONG-JEN YU; Lee J.-H.; Hsu Y.-C.; Chang Y.-L.; Shih J.-Y.; Yang P.-C. |
